Rational Vaccines, Inc.

Woburn, MA · Founded 2015 · CIK 0001641930 · Medtech

Novel HSV type-specific multiplex diagnostic assay for antibody detection in serum

rationalvaccines.com →
Grants
$2.8M
5 awards
Sector median: 1
Raised
$18M
5 Form D · Mar 2020
78 months since last filing
Contracts
—
No federal contracts on record
Patents
10
0 granted · 10 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$269,999
Private capital raisedForm D · SEC$364,000
Private capital raisedForm D · SEC$8,248,749
Private capital raisedForm D · SEC$6,799,994
Private capital raisedForm D · SEC$2,770,000
Federal grantDepartment of Health and Human Services · Phase I · A novel prophylactic and therapeutic vaccine for ocular herpes simplex virus infections$269,616
Federal grantDepartment of Health and Human Services · Phase I · Development of a Highly Specific and Sensitive HSV-1 and HSV-2 Diagnostic Test$291,480
Federal grantDepartment of Health and Human Services · Phase II · Preclinical Evaluation of a Novel Immunomodulatory Vaccine for Preventing and Treating HSV Infections$288,088
Federal grantDepartment of Health and Human Services · Phase II · Preclinical Evaluation of a Novel Immunomodulatory Vaccine for Preventing and Treating HSV Infections$986,717
Federal grantDepartment of Health and Human Services · Phase II · Preclinical Evaluation of a Novel Immunomodulatory Vaccine for Preventing and Treating HSV Infections$999,160
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1382Stasys Medical Corporation—$1.4M
1383Sintact Medical Systems, LLC—$104K
1384Suneva Medical, Inc.—$137M
1385Rational Vaccines, Inc.—$18M
1386DermTech, Inc.—$65M
1387PERIKINETICS INC——
1388PREVENT BIOMETRICS, INC.—$4.2M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 12 related persons
  • Diane AbbittDirector
  • Michael BellDirector
  • Paul BohmExecutive Officer
  • David BrindleyExecutive Officer
  • Jason CammDirector
  • Agustin FernandezDirector · Executive Officer
  • Agustin Fernandez IIIDirector · Executive Officer
  • Aziz FriedrichExecutive Officer
  • William HalfordDirector · Executive Officer
  • Olivier JarryExecutive Officer
  • Jeffrey MaddenDirector
  • Andrew PageDirector

Patents

USPTO · 0 granted of 10
  • Mutant Herpesvirus And Vaccine Compositionsapplication
  • METHODS AND KITS FOR DETERMINING SEROSTATUS OF SARS-CoV-2application
  • Vaccines For Intracellular Pathogens And Methods Of Productionapplication
  • Mutant Herpesvirus And Vaccine Compositionsapplication
  • Methods And Kits For Determining Serostatus Of SARS-COV-2application
  • Vaccines For Intracellular Pathogens And Methods Of Productionapplication
  • Mutant Herpesvirus And Vaccine Compositionsapplication
  • METHODS AND KITS FOR DETERMINING SEROSTATUS OF SARS-CoV-2application
  • METHODS AND KITS FOR DETERMINING SEROSTATUS OF SARS-CoV-2application
  • Vaccines For Intracellular Pathogens And Methods Of Productionapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.